Clinical trial

Photodynamic Therapy Using Lutetium Texaphyrin in Treating Patients With…

NCT00005808 · National Cancer Institute (NCI), NIH · Terminated

Key facts

NCT number NCT00005808
Title Photodynamic Therapy Using Lutetium Texaphyrin in Treating Patients With Cervical Intraepithelial Neoplasia
Official title Phase I Study Photodynamic Therapy Using Lutrin (Lutetium Texaphyrin) in the Treatment of Patients With Cervical Intraepithelial Neoplasia
Lead sponsor National Cancer Institute (NCI), NIH
Status Terminated
Phase Phase 1
Study type Interventional
Conditions Cervical Cancer, Cervical Intraepithelial Neoplasia Grade 2, Cervical Intraepithelial Neoplasia Grade 3
Intervention type Drug, Other, Procedure
Interventions motexafin lutetium, photodynamic therapy, loop electrosurgical excision procedure, laboratory biomarker analysis
Enrollment 54
Start date Dec 1, 2000
Primary completion Apr 1, 2004
First posted Jan 27, 2003
Last update posted Feb 7, 2013
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies